Teaching Interests
BSC 476/576 Molecular Biology
BSC 478L/578L Molecular Biology Laboratory
BSC 481/581 Pathogenic Microbiology
Research Interests
In my laboratory, we are interested in
molecular mechanisms of virulence and our research
program focuses on various aspects of virulence in
pathogenic bacteria. Specifically, we are interested in
the Gram-positive opportunistic pathogen
Staphylococcus aureus.
Staphlococcus aureus causes a
variety of hospital- and community-acquired infections
that range from superficial (i.e., impetigo, cellulitis)
to severe (i.e. osteomyelitis, endocarditis). The
emergence of strains resistant to vancomycin, an
antibiotic of "last resort," coupled with the lack of an
anti-staphylococcal vaccine have made this pathogen an
increasingly serious health problem. The success of
S. aureus as a pathogen is due to its extensive
virulence factors that allow for invasion of virtually
every organ system. There is an urgent need to develop
novel therapeutic agents to control S. aureus
infections. Included among the potential therapeutic
targets are global regulatory systems of virulence
factors. Two global regulators are central for
coordinating the expression of most known virulence
factors: the accessory gene regulator (agr) and
the staphylococcal accessory regulator (sarA).
agr is a quorum-sensing system that is
responsible for up-regulating the production of
exoproteins and repressing the cell-bound proteins at
the transition from exponential to postexponential
growth phases. This system is crucial in infection
because it allows S. aureus to shift from
colonization to invasion. The second global regulator,
sarA, has been shown to activate agr
and therefore regulates virulence factors indirectly.
SarA protein has also been shown to directly
repress transcription of the genes encoding several
virulence factors including the collagen binding adhesin
(cna) in an agr-independent fashion.
My laboratory currently focuses on
finding and characterizing novel regulatory elements
that modulate sarA function or control
virulence in S. aureus. The ultimate goal of
our research program is to identify new therapeutic
targets to combat staphylococcal infections.
In collaborations with Dr. Lowe
(Chemistry and Biochemistry), Dr. Mathias (Polymer
Science) and Dr. Wicks (Polymer Science), we are also
developing antimicrobial surfaces by synthesizing and
testing polymers that may be used coating on medical
devices to prevent nosocomial infections.
Representative Publications
Sambanthamoorthy, Karthik, Mark S.
Smeltzer and Mohamed O. Elasri. 2006. Identification and
characterization of msa (SA1233), a gene involved in
expression of SarA and several virulence factors in
Staphylococcus aureus. Microbiology. 152:
2559-2572.
Nagarajan, Vijayaraj., Navodit Kaushik, Beddhu Murali,
Chaoyang Zhang, Sanyogita Lakhera, Mohamed O. Elasri and
Youping Deng. 2006. A Fourier Transformation based
Method to Mine Peptide Space for Antimicrobial Activity.
BMC Bioinformatics. 7 Suppl 2:S2.
Dizman, Bekir, Mohamed O. Elasri, Lon J. Mathias. 2006.
Synthesis and Characterization of Antibacterial and
Temperature Responsive Methacrylamide Polymers.
Macromolecules. 39(17): 5738-5746.
Ward, Marty, Melissa Sanchez, Mohamed O. Elasri and
Andrew B. Lowe. 2006. Antimicrobial Activity of
Statistical Polymethacrylic Sulfobetaines Against Gram
Positive and Gram Negative Bacteria. Journal of
Applied Polymer Science. 101: 1036–1041.
Dizman, Bekir, Mohamed O. Elasri, Lon J. Mathias. 2005.
Synthesis, Characterization, and Antibacterial
Activities of Novel Methacrylate Polymers Containing
Norfloxacin. Biomacromolecules. 6(1): 514-520.
Blevins, Jon S., Mohamed O. Elasri, Scott D.
Allmendinger, Karen E. Beenken, Robert A. Skinner, J.
Roby Thomas, and Mark S. Smeltzer. 2003. Role of sarA in
the pathogenesis of Staphylococcus aureus
musculoskeletal infection. Infection and Immunity
71: 516-523.
Elasri, Mohamed O., J. Roby Thomas, Robert A. Skinner,
Jon S. Blevins, Karen E. Beenken, Carl L. Nelson, and
Mark S. Smeltzer. 2002. The Staphylococcus aureus
Collagen Adhesin Contributes to the Pathogenesis of
Osteomyelitis. Bone 30:275-280.
|